city Pune hospital president city Pune

₹140 crore in lockdown period

Reading now: 721
www.livemint.com

₹140 crore in the lockdown period.The PE firm has invested ₹70 crore each in ophthalmology hospital chain Sharp Sight and Pune-based Murli Krishna Pharma Pvt.

Ltd, a formulations maker that focuses on developing novel drug delivery system (NDDS) products."Through its strong technical and R&D capabilities, Murli Krishna Pharma has established itself as a player of repute in manufacturing of complex pharmaceutical formulations.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA